Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SMMT
#671
Summit Therapeutics Inc. Common Stock
16.590
0
+7.66%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+7.66%
Monthly Change
+4.60%
6 month change
-16.47%
Year Change
-16.47%
Previous Close
15.410
0
Open
16.590
0
Bid
Ask
Low
16.590
0
High
16.590
0
Volume
263
Markets
US Stock Market
Healthcare
SMMT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus
Citizens reiterates Summit Therapeutics stock rating on pipeline expansion
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call Transcript
Summit Therapeutics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SMMT) 2026-02-23
Summit Q4 2025 slides: clinical wins offset by 389% EPS miss
Earnings call transcript: Summit Therapeutics Q4 2025 reports significant EPS miss
Summit Therapeutics falls on earnings miss despite progress
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse.
Summit Therapeutics stock hits 52-week low at 14.01 USD